
Recent insider buying activity has been reported for several companies, indicating potential investor confidence. Valeura Energy ($VLE.TO) saw its CEO, Sean Guest, purchase stock, with indications of a significant reserves increase of approximately 42% expected in Q1 2025. The company's stock is currently priced at $5.45 CAD, with a market capitalization of $416 million and an estimated cash build of $210 million by the end of the year. Additionally, the company's estimated free cash flow for fiscal year 2025 is around $110 million. Meanwhile, Immunome ($IMNM) has experienced a notable stock surge, rising 20% over the last two days and 9% on the latest trading day, with a total increase of approximately 45% from its lows. The stock has closed above its 50-day and 100-day moving averages, reflecting strong market interest. IMAX ($IMAX) has also performed well, with its stock up more than 70% this year, driven by positive analyst sentiment.

As management explained, but market ignores, $VLE.TO effectively has 10yrs+ of reserves, most of which doesn’t immediately register on paper, but are easily brought forward a chunk at a time. That’s why reserve continues to grow along with production, despite minimal capex.
$IMNM Closed above the 50 & 100 day. 4 day move of 50%. It could take a slight rest but believe the long term story is far larger. Clay Siegall is a world class pioneer in the industry and made his second 1m purchase of shares this year. He's creating a stellar ADC arsenal just…
$VLE.TO Stock: $5.45 CAD MC: $416m Cash: $156n -> $210m by EOY (my estimate) EV: $206m FY'25 FCF: ~$110m (my estimate) EV/FCF into '25 = 1.9x EV/FCF EOY'25)= < 1.0x Reserves increasing every year